Pharmaceutical Industry Reports cancer metabolism based therapeutics market | Page 3

REPORT DESCRIPTION
Cancer Metabolism Based Therapeutics Market Taxonomy:
By Drug –
CPI-613
Enasidenib
By Indication –
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Metastatic Renal Cell Carcinoma
Melanoma
Others
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/961